Genomics and transmissibility
The Omicron variation of the SARS-CoV-2 genome constitutes 18 261 changes from which more than 97% transformations are show within the coding locale, and the remaining 558 are identified within the extra genic region.11 Changes within the coding locale are 2965 indels and nonsynonymous, and synonymous single-nucleotide polymorphisms (SNPs) transformations are 11 995 and 2743, respectively. 12 For more than 270 million detailed SARS-CoV-2 diseases around the world, the infection has advanced into over 1500 particular Pango lineages.13 Moreover, three other erasures and one inclusion transformation are display exterior the spike protein.
Related Conference of Genomics and transmissibility
March 09-10, 2026
21th International Conference on Allergic Diseases and Clinical Immunology
Singapore City, Singapore
April 16-17, 2026
13th World Congress and Exhibition on Antibiotics and Antibiotic Resistance
London, UK
Genomics and transmissibility Conference Speakers
Recommended Sessions
- Cardiac manifestations of coronavirus
- Coronaviruses (COVID-19)
- COVID-19 and Environmental Health
- COVID-19 Clinical Trails
- COVID-19 Drug design and Development
- Epidemiological Characteristics of COVID-19
- Food and Nutrition
- Genomics and transmissibility
- Infectious Diseases Covid-19
- Mental health
- Monoclonal antibody treatments
- Omicron
- SARS-CoV-2 variants
- Severe Acute Respiratory Syndrome Coronavirus 2
- Therapeutics and COVID-19
- Vaccines
- Virology
Related Journals
Are you interested in
- Antibiotic Prophylaxis - Antibiotics 2026 (UK)
- Antibiotic Resistance: Opportunities and Challenges - Antibiotics 2026 (UK)
- Antibiotic-resistant Bacterial infections - Antibiotics 2026 (UK)
- Antibiotics - Antibiotics 2026 (UK)
- Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- Antibiotics: In Pregnancy and Lactation - Antibiotics 2026 (UK)
- Antimicrobial Peptides - Antibiotics 2026 (UK)
- Antimicrobial Therapy - Antibiotics 2026 (UK)
- Clinical Trials of Antibiotics - Antibiotics 2026 (UK)
- Current Research in Antibiotic Resistance - Antibiotics 2026 (UK)
- Developing Alternatives to Antibiotics - Antibiotics 2026 (UK)
- Drug Discovery and Novel Delivery Technologies - Antibiotics 2026 (UK)
- Immunology & Vaccines - Antibiotics 2026 (UK)
- Infectious Diseases - Antibiotics 2026 (UK)
- Mechanisms and Evolution of Antibiotic Resistance - Antibiotics 2026 (UK)
- Micro Organisms in Recent Drug Discovery - Antibiotics 2026 (UK)
- Microorganisms Producing Antibiotics - Antibiotics 2026 (UK)
- Modern Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- New antibiotics and non-antibiotic approaches - Antibiotics 2026 (UK)
- Pharmacokinetics and Pharmacodynamics of Antimicrobial Drugs - Antibiotics 2026 (UK)
- Pharmacology & Toxicology - Antibiotics 2026 (UK)
- Prevention and Control of Antibiotic Resistance - Antibiotics 2026 (UK)
- The Next Generation Approach of Antibiotics - Antibiotics 2026 (UK)